Clinical Trial Update: Study of Descartes-30 in Acute Respiratory Distress Syndrome [Phase 1]

View source ↗

Summary

Phase 1 study of Descartes-30 for Acute Respiratory Distress Syndrome was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Descartes-30

Snippet

Sponsor: Cartesian Therapeutics | Conditions: Acute Respiratory Distress Syndrome, Covid19 | Phase 1 | Status: TERMINATED | Results posted: 2024-10-29